TrialLeukemia2025

Olverembatinib combined with venetoclax and reduced-intensity chemotherapy for adult newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a single-center, single-arm, phase 2 trial.

Xiaoyuan Gong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.